Ophthalmic formulations and uses thereof
US11786518B2 · kind B2 · utility
7Cited by
47References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2020 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Jun 9, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a reproxalap ophthalmic solution, and methods of using the same for treating a disease or disorder such as allergic conjunctivitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.